Neurodex Inc

NeuroDex is transforming precision medicine for neurodegenerative diseases. We improve brain health by delivering accessible, exosome-based biomarkers and accelerating the development of advanced blood tests and therapies.
Focused on Lewy body dementia, Alzheimer’s, Parkinson’s, and ALS, NeuroDex uses proprietary cell-specific exosome isolation and ultra-sensitive biomarker detection to develop next-generation diagnostics for synucleinopathies and related disorders. For more information, visit our website at: 
https://neurodex.co